Reply from authors re: Steven A. Kaplan. Tadalafil for the Treatment of Benign Prostatic Hyperplasia: When the moment does not add Up. Eur Urol 2013;63:517-8: Tadalafil in the treatment of men with lower urinary tract symptoms and/or erectile dysfunction symptoms

European Urology

Volumn 63, Issue 3, 2013, Pages 519-520

  Giuliano, François ^a   Viktrup, Lars ^b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; PLACEBO; TADALAFIL; TAMSULOSIN;

DRUG EFFICACY; DRUG SAFETY; ERECTILE DYSFUNCTION; HUMAN; LOWER URINARY TRACT SYMPTOM; MALE; NOTE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; URINE FLOW RATE;

EID: 84872977882     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.12.020     Document Type: Editorial

References (14)

1. S.A. Kaplan Tadalafil for the treatment of benign prostatic hyperplasia: when the moment does not add up Eur Urol 63 2013 517 518
2. F. Giuliano, S. Ückert, M. Maggi, L. Birder, J. Kissel, and L. Viktrup The mechanism of action of phosphodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia Eur Urol 63 2013 506 516
3. R.B. Egerdie, S. Auerbach, and C.G. Roehrborn Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study J Sex Med 9 2012 271 281
4. M. Oelke, F. Giuliano, V. Mirone, L. Xu, D. Cox, and L. Viktrup Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial Eur Urol 61 2012 917 925
5. H. Porst, E.D. Kim, and A.R. Casabé Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial Eur Urol 60 2011 1105 1113
6. C.G. Roehrborn, K.T. McVary, A. Elion-Mboussa, and L. Viktrup Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study J Urol 180 2008 1228 1234
7. M.J. Barry, F.J. Fowler Jr., and M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia J Urol 148 1992 1549 1557
8. M.J. Barry, W.O. Williford, and Y. Chang Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol 154 1995 1770 1774
9. Oelke M, Bachmann A, Descaueaud A, et al. Guidelines on the management of male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). European Association of Urology Web site. http://www.uroweb.org/gls/pdf/ 12-Male-LUTS-LR.pdf. Updated February 2012. Accessed November 2012.
10. McVary KT, Roehrborn CG, Avins AL, et al. American Urological Association guideline: management of benign prostatic hyperplasia (BPH). http://www.auanet.org/content/clinical-practice-guidelines/clinical-guidelines. cfm?sub=bph. Accessed November 2012.
11. Flomax [US package insert]. Ridgefield, CT: Boehrringer Ingelheim Pharmaceuticals; 2011.
12. Uroxatral [US package insert]. Bridgewater, NJ: Sanofi-Aventis; 2010.
13. R. Dmochowski, C. Roehrborn, S. Klise, L. Xu, J. Kaminetsky, and S. Kraus Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial J Urol 183 2010 1092
14. E. Kim, A. Seftel, E. Goldfischer, X. Ni, and P. Burns Tadalafil once daily following PRN phosphodiesteraset 5 inhibitor treatment: an assessment of return to normal erectile function J Sex Med 9 Suppl 4 2012 299 302